REPLY
Chronic Hepatitis C Virus Infection

Steven K. Herrine, MD
2 September 2003 | Volume 139 Issue 5 Part 1 | Page W-68
IN RESPONSE:
Dr. Kleinhaus's anecdote successfully describes the limitations of HCV tests. Although the accuracy of molecular testing for HCV and its subtypes has improved over the past several years, the diagnosis of HCV needs to made in the context of the clinical scenario. If the patient in question has a known risk factor and elevated aminotransferase levels, true infection is more likely. From a technical standpoint, discrepancies between HCV viral measures and genotyping may be seen at very low viral loads, since the primers used for these tests differ. Other causes of discordant test results may be a sample mix-up or reaction failure due to a variety of technical reasons. Retesting the patient using a fresh specimen often resolves these issues.
|
Author and Article Information
|
|---|
Top
Author & Article Info
|
|---|
From Thomas Jefferson University; Philadelphia, PA 19107.
Acknowledgment: The author thanks David Gretch, MD, PhD, for consultation on this matter.
About Letters
The Editors welcome submissions for possible publication in the Letters section. Authors of letters should:
Include no more than 300 words of text, three authors, and five references
Type with double-spacing
Send three copies of the letter, an authors' form signed by all authors, and a cover letter describing any conflicts of interest related to the contents of the letter.
Letters commenting on an Annals article will be considered if they are received within 6 weeks of the time the article was published. Only some of the letters received can be published. Published letters are edited and may be shortened; tables and figures are included only selectively. Authors will be notified that the letter has been received. If the letter is selected for publication, the author will be notified about 3 weeks before the publication date. Unpublished letters cannot be returned.
Annals welcomes electronically submitted letters.